Attached files
| file | filename |
|---|---|
| EX-2.3 - AMENDMENT TO CERTIFICATE OF INCORPORATION - Mansfield-Martin Exploration Mining, Inc. | ex2three.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 1, 2014
| MED-CANNABIS PHARMA, INC. |
(Exact Name of Registrant as Specified in its Charter)
| Nevada | 000-54770 | 45-0704149 | ||
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 12655 N Central Expressway Suite 100, Dallas TX 75243 |
| (Address of Principal Executive Office) (Zip Code) |
Registrant's telephone number, including area code: 214-666-8364
SW CHINA IMPORTS, INC.
(former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| 1 |
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On May 15, 2014, as a result of its recent acquisition, SW China Imports, Inc. (the “Company”) amended its Certificate of Incorporation to change its name to Med-Cannabis Pharma, Inc. The Company received approval of approximately 76.16% of its outstanding shares for the amendment of its Articles of Incorporation.
As a result of the name change, the Company’s trading symbol was changed to “MCPI.OB” effective July 1, 2014.
Item 5.07 Submission of Matters to a Vote of Security Holders.
In connection with the amendment to the Company’s Articles of Incorporation, the Company received the written consent of its majority shareholder, owning approximately 76.16% of the issued and outstanding shares of the Company’s common stock, approving the amendment.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. | Description of Exhibit |
| 2.3* | Amendment to Certificate of Incorporation |
__________
*filed herewith
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| July 2, 2014 | MED-CANNABIS PHARMA, INC. |
| /s/ Graciela Moreno | |
| Graciela Moreno, CEO |
| 2 |